Celldex Therapeutics, Inc. Operating Income
Celldex Therapeutics, Inc. (CLDX) reported Operating Income of -$80.62 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Income Statement
us-gaap:OperatingIncomeLoss · last filed 2026-08-06
- Celldex Therapeutics, Inc. operating income (loss) for the quarter ending 2026-06-30 was -$80.62M.
- Celldex Therapeutics, Inc. operating income (loss) for the quarter ending 2026-03-31 was -$84.44M.
- Celldex Therapeutics, Inc. operating income (loss) for the quarter ending 2025-12-31 was -$87.15M.
- Celldex Therapeutics, Inc. operating income (loss) for the quarter ending 2025-09-30 was -$73.62M.
- Celldex Therapeutics, Inc. operating income (loss) for fiscal 2025 was -$287.37M.
- Celldex Therapeutics, Inc. operating income (loss) for fiscal 2024 was -$195.08M.
- Celldex Therapeutics, Inc. operating income (loss) for fiscal 2023 was -$154.54M.
- Celldex Therapeutics, Inc. operating income (loss) for fiscal 2022 was -$115.23M.
| Period end | Operating Income (Loss) 3 month | Operating Income (Loss) 6 month | Operating Income (Loss) 9 month | Operating Income (Loss) 12 month |
|---|---|---|---|---|
| 2026-06-30 | -$80.62M 10-Q · filed 2026-08-06 | -$165.06M 10-Q · filed 2026-08-06 | -$252.21M derived: sum of 3 quarters · filed 2026-08-06 | -$325.83M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | -$84.44M 10-Q · filed 2026-05-07 | -$171.59M derived: sum of 2 quarters · filed 2026-05-07 | -$245.21M derived: sum of 3 quarters · filed 2026-05-07 | -$309.06M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | -$87.15M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$160.77M derived: sum of 2 quarters · filed 2026-02-25 | -$224.63M derived: sum of 3 quarters · filed 2026-08-06 | -$287.37M 10-K · filed 2026-02-25 |
| 2025-09-30 | -$73.62M 10-Q · filed 2025-11-10 | -$137.47M derived: sum of 2 quarters · filed 2026-08-06 | -$200.21M 10-Q · filed 2025-11-10 | -$256.24M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | -$63.86M 10-Q · filed 2026-08-06 | -$126.60M 10-Q · filed 2026-08-06 | -$182.62M derived: sum of 3 quarters · filed 2026-08-06 | -$234.75M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | -$62.74M 10-Q · filed 2026-05-07 | -$118.77M derived: sum of 2 quarters · filed 2026-05-07 | -$170.89M derived: sum of 3 quarters · filed 2026-05-07 | -$217.21M derived: sum of 4 quarters · filed 2026-05-07 |
| 2024-12-31 | -$56.03M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$108.15M derived: sum of 2 quarters · filed 2026-02-25 | -$154.47M derived: sum of 3 quarters · filed 2026-02-25 | -$195.08M 10-K · filed 2026-02-25 |
| 2024-09-30 | -$52.13M 10-Q · filed 2025-11-10 | -$98.44M derived: sum of 2 quarters · filed 2025-11-10 | -$139.05M 10-Q · filed 2025-11-10 | -$186.68M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-06-30 | -$46.32M 10-Q · filed 2025-08-07 | -$86.92M 10-Q · filed 2025-08-07 | -$134.55M derived: sum of 3 quarters · filed 2026-02-25 | -$175.79M derived: sum of 4 quarters · filed 2026-02-25 |
| 2024-03-31 | -$40.61M 10-Q · filed 2025-05-08 | -$88.23M derived: sum of 2 quarters · filed 2026-02-25 | -$129.47M derived: sum of 3 quarters · filed 2026-02-25 | -$162.68M derived: sum of 4 quarters · filed 2026-02-25 |
| 2023-12-31 | -$47.63M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25 | -$88.87M derived: sum of 2 quarters · filed 2026-02-25 | -$122.07M derived: sum of 3 quarters · filed 2026-02-25 | -$154.54M 10-K · filed 2026-02-25 |
| 2023-09-30 | -$41.24M 10-Q · filed 2024-11-06 | -$74.44M derived: sum of 2 quarters · filed 2024-11-06 | -$106.92M 10-Q · filed 2024-11-06 | -$134.80M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-06-30 | -$33.20M 10-Q · filed 2024-08-08 | -$65.68M 10-Q · filed 2024-08-08 | -$93.56M derived: sum of 3 quarters · filed 2025-02-27 | -$121.26M derived: sum of 4 quarters · filed 2025-02-27 |
| 2023-03-31 | -$32.47M 10-Q · filed 2024-05-06 | -$60.36M derived: sum of 2 quarters · filed 2025-02-27 | -$88.05M derived: sum of 3 quarters · filed 2025-02-27 | -$124.45M derived: sum of 4 quarters · filed 2025-02-27 |
| 2022-12-31 | -$27.89M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27 | -$55.58M derived: sum of 2 quarters · filed 2025-02-27 | -$91.98M derived: sum of 3 quarters · filed 2025-02-27 | -$115.23M 10-K · filed 2025-02-27 |
| 2022-09-30 | -$27.70M 10-Q · filed 2023-11-02 | -$64.09M derived: sum of 2 quarters · filed 2023-11-02 | -$87.35M 10-Q · filed 2023-11-02 | -$107.69M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-06-30 | -$36.40M 10-Q · filed 2023-08-08 | -$59.65M 10-Q · filed 2023-08-08 | -$79.99M derived: sum of 3 quarters · filed 2024-02-26 | -$100.82M derived: sum of 4 quarters · filed 2024-02-26 |
| 2022-03-31 | -$23.26M 10-Q · filed 2023-05-04 | -$43.60M derived: sum of 2 quarters · filed 2024-02-26 | -$64.42M derived: sum of 3 quarters · filed 2024-02-26 | -$77.86M derived: sum of 4 quarters · filed 2024-02-26 |
| 2021-12-31 | -$20.34M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-26 | -$41.16M derived: sum of 2 quarters · filed 2024-02-26 | -$54.60M derived: sum of 3 quarters · filed 2024-02-26 | -$71.24M 10-K · filed 2024-02-26 |
| 2021-09-30 | -$20.82M 10-Q · filed 2022-11-09 | -$34.26M derived: sum of 2 quarters · filed 2022-11-09 | -$50.90M 10-Q · filed 2022-11-09 | -$75.68M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-06-30 | -$13.44M 10-Q · filed 2022-08-08 | -$30.08M 10-Q · filed 2022-08-08 | -$54.86M derived: sum of 3 quarters · filed 2023-02-28 | -$69.20M derived: sum of 4 quarters · filed 2023-02-28 |
| 2021-03-31 | -$16.64M 10-Q · filed 2022-05-05 | -$41.42M derived: sum of 2 quarters · filed 2023-02-28 | -$55.76M derived: sum of 3 quarters · filed 2023-02-28 | -$67.13M derived: sum of 4 quarters · filed 2023-02-28 |
| 2020-12-31 | -$24.78M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-28 | -$39.12M derived: sum of 2 quarters · filed 2023-02-28 | -$50.49M derived: sum of 3 quarters · filed 2023-02-28 | -$63.35M 10-K · filed 2023-02-28 |
| 2020-09-30 | -$14.34M 10-Q · filed 2021-11-09 | -$25.71M derived: sum of 2 quarters · filed 2021-11-09 | -$38.57M 10-Q · filed 2021-11-09 | -$51.56M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-06-30 | -$11.37M 10-Q · filed 2021-08-05 | -$24.23M 10-Q · filed 2021-08-05 | -$37.22M derived: sum of 3 quarters · filed 2022-02-28 | -$49.06M derived: sum of 4 quarters · filed 2022-02-28 |
| 2020-03-31 | -$12.87M 10-Q · filed 2021-05-06 | -$25.86M derived: sum of 2 quarters · filed 2022-02-28 | -$37.70M derived: sum of 3 quarters · filed 2022-02-28 | -$49.96M derived: sum of 4 quarters · filed 2022-02-28 |
| 2019-12-31 | -$12.99M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-28 | -$24.83M derived: sum of 2 quarters · filed 2022-02-28 | -$37.09M derived: sum of 3 quarters · filed 2022-02-28 | -$55.03M 10-K · filed 2022-02-28 |
| 2019-09-30 | -$11.84M 10-Q · filed 2020-11-05 | -$24.10M derived: sum of 2 quarters · filed 2020-11-05 | -$42.04M 10-Q · filed 2020-11-05 | -$54.16M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-06-30 | -$12.26M 10-Q · filed 2020-08-06 | -$30.20M 10-Q · filed 2020-08-06 | -$42.32M derived: sum of 3 quarters · filed 2021-03-29 | -$50.09M derived: sum of 4 quarters · filed 2021-03-29 |
| 2019-03-31 | -$17.94M 10-Q · filed 2020-05-06 | -$30.06M derived: sum of 2 quarters · filed 2021-03-29 | -$37.83M derived: sum of 3 quarters · filed 2021-03-29 | -$54.70M derived: sum of 4 quarters · filed 2021-03-29 |
| 2018-12-31 | -$12.12M derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-29 | -$19.89M derived: sum of 2 quarters · filed 2021-03-29 | -$36.76M derived: sum of 3 quarters · filed 2021-03-29 | -$156.44M 10-K · filed 2021-03-29 |
| 2018-09-30 | -$7.76M 10-Q · filed 2019-11-12 | -$24.64M derived: sum of 2 quarters · filed 2019-11-12 | -$144.31M 10-Q · filed 2019-11-12 | -$169.84M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-06-30 | -$16.87M 10-Q · filed 2019-08-07 | -$136.55M 10-Q · filed 2019-08-07 | -$162.08M derived: sum of 3 quarters · filed 2020-03-26 | -$194.04M derived: sum of 4 quarters · filed 2020-03-26 |
| 2018-03-31 | -$119.68M 10-Q · filed 2019-05-07 | -$145.20M derived: sum of 2 quarters · filed 2020-03-26 | -$177.16M derived: sum of 3 quarters · filed 2020-03-26 | -$206.09M derived: sum of 4 quarters · filed 2020-03-26 |
| 2017-12-31 | -$25.53M derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-26 | -$57.49M derived: sum of 2 quarters · filed 2020-03-26 | -$86.42M derived: sum of 3 quarters · filed 2020-03-26 | -$121.53M 10-K · filed 2020-03-26 |
| 2017-09-30 | -$31.96M 10-Q · filed 2018-11-07 | -$60.89M derived: sum of 2 quarters · filed 2018-11-07 | -$96.00M 10-Q · filed 2018-11-07 | -$130.85M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-06-30 | -$28.93M 10-Q · filed 2018-08-08 | -$64.04M 10-Q · filed 2018-08-08 | -$98.89M derived: sum of 3 quarters · filed 2019-03-07 | -$128.88M derived: sum of 4 quarters · filed 2019-03-07 |
| 2017-03-31 | -$35.11M 10-Q · filed 2018-05-10 | -$69.96M derived: sum of 2 quarters · filed 2019-03-07 | -$99.96M derived: sum of 3 quarters · filed 2019-03-07 | -$132.32M derived: sum of 4 quarters · filed 2019-03-07 |
| 2016-12-31 | -$34.85M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-07 | -$64.84M derived: sum of 2 quarters · filed 2019-03-07 | -$97.21M derived: sum of 3 quarters · filed 2019-03-07 | -$132.92M 10-K · filed 2019-03-07 |
| 2016-09-30 | -$29.99M 10-Q · filed 2017-11-07 | -$62.36M derived: sum of 2 quarters · filed 2017-11-07 | -$98.06M 10-Q · filed 2017-11-07 | -$131.50M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-06-30 | -$32.37M 10-Q · filed 2017-08-08 | -$68.07M 10-Q · filed 2017-08-08 | -$101.51M derived: sum of 3 quarters · filed 2018-03-07 | -$133.88M derived: sum of 4 quarters · filed 2018-03-07 |
| 2016-03-31 | -$35.70M 10-Q · filed 2017-05-09 | -$69.14M derived: sum of 2 quarters · filed 2018-03-07 | -$101.51M derived: sum of 3 quarters · filed 2018-03-07 | -$134.26M derived: sum of 4 quarters · filed 2018-03-07 |
| 2015-12-31 | -$33.44M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-07 | -$65.81M derived: sum of 2 quarters · filed 2018-03-07 | -$98.56M derived: sum of 3 quarters · filed 2018-03-07 | -$129.54M 10-K · filed 2018-03-07 |
| 2015-09-30 | -$32.37M 10-Q · filed 2016-11-07 | -$65.12M derived: sum of 2 quarters · filed 2016-11-07 | -$96.10M 10-Q · filed 2016-11-07 | -$128.15M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-06-30 | -$32.75M 10-Q · filed 2016-08-08 | -$63.73M 10-Q · filed 2016-08-08 | -$95.78M derived: sum of 3 quarters · filed 2017-03-14 | -$126.12M derived: sum of 4 quarters · filed 2017-03-14 |
| 2015-03-31 | -$30.98M 10-Q · filed 2016-05-05 | -$63.03M derived: sum of 2 quarters · filed 2017-03-14 | -$93.37M derived: sum of 3 quarters · filed 2017-03-14 | -$121.92M derived: sum of 4 quarters · filed 2017-03-14 |
| 2014-12-31 | -$32.05M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-14 | -$62.39M derived: sum of 2 quarters · filed 2017-03-14 | -$90.94M derived: sum of 3 quarters · filed 2017-03-14 | -$122.43M 10-K · filed 2017-03-14 |
| 2014-09-30 | -$30.34M 10-Q · filed 2015-11-05 | -$58.89M derived: sum of 2 quarters · filed 2015-11-05 | -$90.38M 10-Q · filed 2015-11-05 | -$112.49M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-06-30 | -$28.55M 10-Q · filed 2015-08-10 | -$60.04M 10-Q · filed 2015-08-10 | -$82.15M derived: sum of 3 quarters · filed 2016-02-25 | -$105.42M derived: sum of 4 quarters · filed 2016-02-25 |
| 2014-03-31 | -$31.49M 10-Q · filed 2015-04-29 | -$53.60M derived: sum of 2 quarters · filed 2016-02-25 | -$76.87M derived: sum of 3 quarters · filed 2016-02-25 | -$95.53M derived: sum of 4 quarters · filed 2016-02-25 |
| 2013-12-31 | -$22.11M derived: 10-K/A 12 month − 10-Q 9 month · filed 2016-02-25 | -$45.38M derived: sum of 2 quarters · filed 2016-02-25 | -$64.04M derived: sum of 3 quarters · filed 2016-02-25 | -$81.44M 10-K/A · filed 2016-02-25 |
| 2013-09-30 | -$23.27M 10-Q · filed 2014-11-05 | -$41.93M derived: sum of 2 quarters · filed 2014-11-05 | -$59.33M 10-Q · filed 2014-11-05 | -$75.88M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-06-30 | -$18.66M 10-Q · filed 2014-08-07 | -$36.06M 10-Q · filed 2014-08-07 | -$52.61M derived: sum of 3 quarters · filed 2015-02-24 | -$67.36M derived: sum of 4 quarters · filed 2015-02-24 |
| 2013-03-31 | -$17.40M 10-Q · filed 2014-05-01 | -$33.95M derived: sum of 2 quarters · filed 2015-02-24 | -$48.70M derived: sum of 3 quarters · filed 2015-02-24 | -$62.19M derived: sum of 4 quarters · filed 2015-02-24 |
| 2012-12-31 | -$16.55M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$31.30M derived: sum of 2 quarters · filed 2015-02-24 | -$44.79M derived: sum of 3 quarters · filed 2015-02-24 | -$58.08M 10-K · filed 2015-02-24 |
| 2012-09-30 | -$14.75M 10-Q · filed 2013-11-08 | -$28.24M derived: sum of 2 quarters · filed 2013-11-08 | -$41.53M 10-Q · filed 2013-11-08 | -$53.91M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-06-30 | -$13.49M 10-Q · filed 2013-08-06 | -$26.78M 10-Q · filed 2013-08-06 | -$39.16M derived: sum of 3 quarters · filed 2014-03-03 | -$50.64M derived: sum of 4 quarters · filed 2014-03-03 |
| 2012-03-31 | -$13.29M 10-Q · filed 2013-05-03 | -$25.67M derived: sum of 2 quarters · filed 2014-03-03 | -$37.15M derived: sum of 3 quarters · filed 2014-03-03 | -$47.03M derived: sum of 4 quarters · filed 2014-03-03 |
| 2011-12-31 | -$12.38M derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-03 | -$23.86M derived: sum of 2 quarters · filed 2014-03-03 | -$33.74M derived: sum of 3 quarters · filed 2014-03-03 | -$43.40M 10-K · filed 2014-03-03 |
| 2011-09-30 | -$11.48M 10-Q · filed 2012-11-02 | -$21.36M derived: sum of 2 quarters · filed 2012-11-02 | -$31.02M 10-Q · filed 2012-11-02 | -$9.90M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-06-30 | -$9.88M 10-Q · filed 2012-08-09 | -$19.54M 10-Q · filed 2012-08-09 | $1.58M derived: sum of 3 quarters · filed 2013-03-08 | -$7.30M derived: sum of 4 quarters · filed 2013-03-08 |
| 2011-03-31 | -$9.66M 10-Q · filed 2012-05-04 | $11.46M derived: sum of 2 quarters · filed 2013-03-08 | $2.58M derived: sum of 3 quarters · filed 2013-03-08 | -$6.71M derived: sum of 4 quarters · filed 2013-03-08 |
| 2010-12-31 | $21.12M derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-08 | $12.24M derived: sum of 2 quarters · filed 2013-03-08 | $2.95M derived: sum of 3 quarters · filed 2013-03-08 | -$6.46M 10-K · filed 2013-03-08 |
| 2010-09-30 | -$8.88M 10-Q · filed 2011-11-03 | -$18.16M derived: sum of 2 quarters · filed 2011-11-03 | -$27.57M 10-Q · filed 2011-11-03 | |
| 2010-06-30 | -$9.29M 10-Q · filed 2011-08-04 | -$18.69M 10-Q · filed 2011-08-04 | ||
| 2009-12-31 | -$36.85M 10-K · filed 2012-03-08 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NEOGEN CORP (NEOG) | United States | $2.979B | -247.49 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |